Patents by Inventor Elaina Marie GARTNER

Elaina Marie GARTNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
    Publication number: 20230364254
    Abstract: Provided herein are methods for treating cancers with antibody drug conjugates (ADC) that bind to 191P4DI2 protein (Nectin-4).
    Type: Application
    Filed: October 8, 2021
    Publication date: November 16, 2023
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Elaina Marie GARTNER, Eric John CHOWN, Tina KIM-HAFKEN, Dana Ann KENNEDY
  • METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
    Publication number: 20230330251
    Abstract: Provided herein are methods for the treatment of cancers with antibody drug conjugates (ADC) that bind to 191P4D12 proteins.
    Type: Application
    Filed: September 16, 2021
    Publication date: October 19, 2023
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventor: Elaina Marie GARTNER
  • TREATMENT OF CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
    Publication number: 20230025600
    Abstract: Provided herein are methods for the treatment of cancers with antibody drug conjugates (ADC) that bind to 191P4D12 proteins. Also provided herein are methods for the treatment of urothelial cancer using an antibody drug conjugate (ADC) that binds 191P4D12. Additionally provided herein are methods for the treatment of solid tumors using an antibody drug conjugate (ADC) that binds 191P4DI2.
    Type: Application
    Filed: November 24, 2020
    Publication date: January 26, 2023
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Elaina Marie GARTNER, Amal MELHEM-BERTRANDT, Leonard Michael Jude REYNO, Jonathan Gregor DRACHMAN